发明名称 NOVEL IL-17A BINDING MOLECULES AND MEDICAL USES THEREOF
摘要 The present invention relates to a polypeptide inhibiting the activity of glycosylated IL-17A, wherein the polypeptide comprises or consists of an amino acid sequence selected from the group consisting of: (a) GVTLFVALYDY(X1)(X2)(X3)(X4)(X5)(X6) DLSFHKGEKFQIL STHEYEDWWEARSLTTGETGYIPSNYVAPVDSIQ (SEQ ID NO: 1), wherein amino acid positions (X1) to (X6) may be any amino acid sequence; and (b) an amino acid sequence which is at least 85% identical to the amino acid sequence of (a), wherein the identity determination excludes amino acid positions (X1) to (X6) and provided that the amino acid sequence STHEYE (SEQ ID NO: 2) in amino acid positions 31 to 36 of SEQ ID NO: 1 is conserved. The invention also relates to fusion constructs, compositions and medical uses comprising said polypeptide.
申请公布号 US2015322125(A1) 申请公布日期 2015.11.12
申请号 US201314428245 申请日期 2013.09.19
申请人 COVAGEN AG 发明人 SILACCI MELKKO Michela;BANZIGER Nadja;WOODS Richard;ZHA Wenjuan;ATTINGER Isabella;SANTIMARIA Roger;LEMBKE Wibke;BATEY Sarah;VON DER BEY Ulrike;BERTSCHINGER Julian;GRABULOVSKI Dragan
分类号 C07K14/47;A61K38/17;C07K16/24 主分类号 C07K14/47
代理机构 代理人
主权项 1. A polypeptide that inhibits the activity of glycosylated comprising or consisting of an amino acid sequence comprising: (a)(SEQ ID NO: 1)GVTLEVALYDY(X1)(X2)(X3)(X4)(X5)(X6)DLSFHKGEKFQILSTHEYEDWWEARSLTTGETGYIPSNYVAPVDSIQ,wherein amino acid positions (X1) to (X6) may be any amino acid sequence; or (b) an amino acid sequence at least 85% identical to the amino acid sequence of (a), wherein the identity determination excludes amino acid positions (X1) to (X6) and provided that the amino acid sequence STHEYE (SEQ ID NO: 2) in amino acid positions 31 to 36 of SEQ ID NO: 1 is conserved.
地址 Zürich-Schlieren CH